首页|期刊导航|癌症生物学与医学(英文版)|Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma
癌症生物学与医学(英文版)2025,Vol.22Issue(4):301-321,21.DOI:10.20892/j.issn.2095-3941.2024.0538
Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma
Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma
摘要
关键词
Chimeric antigen receptor-T cell/lymphoma/cytotherapy/immunotherapy/epigenetics/metabolismKey words
Chimeric antigen receptor-T cell/lymphoma/cytotherapy/immunotherapy/epigenetics/metabolism引用本文复制引用
Tianshu Yu,Xianhuo Wang,Ou Bai,Huilai Zhang,Wenbin Qian..Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma[J].癌症生物学与医学(英文版),2025,22(4):301-321,21.基金项目
This work was supported by grants from the Science Technology Department of Zhejiang Province(Grant No.2021C03117),Noncommunicable Chronic Diseases-National Science and Technology Major Project(Grant No.2023ZD0501300),National Natural Science Foundation of China(Grant No.82170219),and Zhejiang Provincial Natural Science Foundation of China(Grant No.LQ24H080009). (Grant No.2021C03117)